GSK215 is a potent and selective PROTAC degrader of focal adhesion kinase (FAK), achieving degradation with a pDC50 of 8.4. It is built from the FAK inhibitor VS-4718 and a VHL E3 ligase ligand, enabling rapid and sustained FAK loss, a valuable tool for studying FAK biology in cancer and metastasis research both in vitro and in vivo.